BioCity company Tag

Aseptika and BioHub based, Zenzium, Ltd., have been awarded a grant from the UK’s innovation agency to develop a new home-based early warning system for people with severe respiratory disease. Artificial Intelligence (AI) will automatically analyse and learn from data generated by the patient at...

NuVision Biotherapies is delighted to announce the appointment of its new chairman, Dr Mark Treherne.   Mark has a PhD in Pharmacology from Cambridge University along with over 25 years of industrial R&D experience in the discovery and development of novel treatments for diseases with unmet medical...

Last month I was lucky enough to shadow Azotic Technologies for the morning; not only to get a taste of the work they carry out on a day to day basis, but to get insight into the people that work there. David Dent, Director of...

XenoGesis has appointed Dr Rachel Hemsley as global head of business development in a drive to support its ambitious growth plans. The Nottingham-based biotechnology company is the UK's largest independent laboratory-based contract research organisation (CRO) specialising in preclinical drug metabolism and pharmacokinetics (DMPK) – enabling it to provide expert...

BioCity-based marketing agency, V Formation, has hired a senior business journalist to bolster its public relations division.   Lauren Mills, most recently deputy business editor at the Leicester Mercury, has been hired by marketing and PR agency V Formation as senior PR consultant. Lauren steps into the...

All Naturals soaps are now available to purchase via Boots online store. They are the first company to sell ‘all natural' soaps made using the traditional cold process method. This production method is time consuming, however produces a high quality product and is free from chemicals...

Sygnature Discovery, the UK's largest independent provider of integrated drug discovery resource and expertise, has appointed Dr Bruce Sargent as Strategic Business Development Lead for North America to assist with the company’s ambitious growth plans for the USA and Canada. Sygnature Discovery is expanding its business...

The Legal 500 UK 2017 was published earlier this month and AdamsonJones has for the third consecutive year received a Tier 4 position in the PATMA: Patent Attorneys ranking. In addition to the firm's ranking, Simon Cooper, Nic Ferrar and Steve Jones were all recommended. The Legal 500 UK is a third-party reference guide...

Locate Therapeutics, a leading UK regenerative medicine company today announced that it has received a Biomedical Catalyst Primer Award for a potentially breakthrough personalised cell therapy development project.  Called CellFuse, the project is designed to demonstrate the ability of its combined IntraStem synthetic peptide-based intracellular...